TP53 and cancer: The anticancer effect of isorhamnetin is attributed to the ability of this substance to activate apoptotic pathways in cancer cells by upregulating p53 and inducing the expression of the apoptotic factors B-cell lymphoma 2-associated X protein and caspase-2 [27,40].